Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea Syndrome

Objective:Obstructive sleep apnea syndrome (OSAS) is a common disorder among the public and it is associated with many cardio-cerebrovascular consequences. Aspirin is used as the first line of treatment regarding such complications; however, >20% of the patients have drug resistance which causes...

Full description

Bibliographic Details
Main Authors: Utku Oğan Akyıldız, Ali Akyol
Format: Article
Language:English
Published: Galenos Yayinevi 2023-06-01
Series:Türk Uyku Tıbbı Dergisi
Subjects:
Online Access: http://jtsm.org/archives/archive-detail/article-preview/potential-aspirin-resistance-in-patients-with-obst/60441
_version_ 1797813425927094272
author Utku Oğan Akyıldız
Ali Akyol
author_facet Utku Oğan Akyıldız
Ali Akyol
author_sort Utku Oğan Akyıldız
collection DOAJ
description Objective:Obstructive sleep apnea syndrome (OSAS) is a common disorder among the public and it is associated with many cardio-cerebrovascular consequences. Aspirin is used as the first line of treatment regarding such complications; however, >20% of the patients have drug resistance which causes ongoing vulnerability to vascular accidents. The objective of this study is the evaluation of potential aspirin resistance in drug naïve severe OSAS patients.Materials and Methods:Thirty patients with a diagnosis of severe OSAS and 30 age-matched non-OSAS controls enrolled in the study. Urine samples of both patients and controls were analyzed for 11-dehydrothromboxane B2 (11-DHTBXB2) levels and compared afterward. Pairwise comparisons were performed and a two-tailed p-value of <0.05 was considered statistically significant.Results:Biochemical analysis of the urine samples revealed an 11-DHTBXB2 level of 26.7 pg/dL for the patient group, whereas the relative value was 12.7 pg/dL for the control group (p=0.005). The significant increase in urinary 11-DHTBXB2 levels among patients was independent of sex, age, and body mass index.Conclusion:Patients with OSAS had higher levels of urine 11-DHTBXB2 levels, hence higher aspirin resistance than controls. Identification of aspirin resistance and prediction of potential unresponsiveness to first-line antiplatelet therapy is essential in OSAS to guide the primary or secondary prophylaxis in this population who have a marked propensity to vascular insult.
first_indexed 2024-03-13T07:51:49Z
format Article
id doaj.art-22d8c825ddc942d495eae2bf4990cae5
institution Directory Open Access Journal
issn 2148-1504
language English
last_indexed 2024-03-13T07:51:49Z
publishDate 2023-06-01
publisher Galenos Yayinevi
record_format Article
series Türk Uyku Tıbbı Dergisi
spelling doaj.art-22d8c825ddc942d495eae2bf4990cae52023-06-02T11:01:27ZengGalenos YayineviTürk Uyku Tıbbı Dergisi2148-15042023-06-0110216316710.4274/jtsm.galenos.2023.3825813049054Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea SyndromeUtku Oğan Akyıldız0Ali Akyol1 Adnan Menderes University Faculty of Medicine, Department of Neurology, Aydın, Turkey Adnan Menderes University Faculty of Medicine, Department of Neurology, Aydın, Turkey Objective:Obstructive sleep apnea syndrome (OSAS) is a common disorder among the public and it is associated with many cardio-cerebrovascular consequences. Aspirin is used as the first line of treatment regarding such complications; however, >20% of the patients have drug resistance which causes ongoing vulnerability to vascular accidents. The objective of this study is the evaluation of potential aspirin resistance in drug naïve severe OSAS patients.Materials and Methods:Thirty patients with a diagnosis of severe OSAS and 30 age-matched non-OSAS controls enrolled in the study. Urine samples of both patients and controls were analyzed for 11-dehydrothromboxane B2 (11-DHTBXB2) levels and compared afterward. Pairwise comparisons were performed and a two-tailed p-value of <0.05 was considered statistically significant.Results:Biochemical analysis of the urine samples revealed an 11-DHTBXB2 level of 26.7 pg/dL for the patient group, whereas the relative value was 12.7 pg/dL for the control group (p=0.005). The significant increase in urinary 11-DHTBXB2 levels among patients was independent of sex, age, and body mass index.Conclusion:Patients with OSAS had higher levels of urine 11-DHTBXB2 levels, hence higher aspirin resistance than controls. Identification of aspirin resistance and prediction of potential unresponsiveness to first-line antiplatelet therapy is essential in OSAS to guide the primary or secondary prophylaxis in this population who have a marked propensity to vascular insult. http://jtsm.org/archives/archive-detail/article-preview/potential-aspirin-resistance-in-patients-with-obst/60441 obstructive sleep apnea syndromeosasaspirinacetilsalyciclic acidresistanceaspirin unresponsivenesscardiovascular morbidity
spellingShingle Utku Oğan Akyıldız
Ali Akyol
Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea Syndrome
Türk Uyku Tıbbı Dergisi
obstructive sleep apnea syndrome
osas
aspirin
acetilsalyciclic acid
resistance
aspirin unresponsiveness
cardiovascular morbidity
title Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea Syndrome
title_full Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea Syndrome
title_fullStr Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea Syndrome
title_full_unstemmed Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea Syndrome
title_short Potential Aspirin Resistance in Patients with Obstructive Sleep Apnea Syndrome
title_sort potential aspirin resistance in patients with obstructive sleep apnea syndrome
topic obstructive sleep apnea syndrome
osas
aspirin
acetilsalyciclic acid
resistance
aspirin unresponsiveness
cardiovascular morbidity
url http://jtsm.org/archives/archive-detail/article-preview/potential-aspirin-resistance-in-patients-with-obst/60441
work_keys_str_mv AT utkuoganakyıldız potentialaspirinresistanceinpatientswithobstructivesleepapneasyndrome
AT aliakyol potentialaspirinresistanceinpatientswithobstructivesleepapneasyndrome